Brazil’s health regulator greenlights trials of new Chinese vaccine
Brazilian health regulator Anvisa has authorized clinical trials of a new COVID vaccine developed by China’s Sichuan Clover Biopharmaceuticals, according...
April 19, 2021Topic
Anvisa
Brazil’s Anvisa rejects bid to import Bharat Biotech vaccine
Brazilian health regulator Anvisa on Wednesday, March 31, rejected a request from the government to import doses of Covaxin, the...
March 31, 2021
Brazil’s health regulator relaxes rules for oxygen cylinders to counter shortages
Facing the risk of collapse in the health system, the National Health Regulation Agency (Anvisa) relaxed the rules about oxygen...
March 20, 2021
U.S. pressured Brazil not to buy Sputnik V, Trump administration document shows
The Brazilian government announced on Saturday the purchase of 10 million doses of the Russian vaccine.
March 16, 2021
Brazil eyes July for full local production of Oxford/AstraZeneca vaccine
Brazil could begin full production of AstraZeneca Plc’s COVID-19 vaccine by July if regulators allow, an official at biomedical center...
March 15, 2021
ANVISA approves limited use of Remdesivir; AstraZeneca/Fiocruz vaccines approved for general use
Remdesivir, the first drug approved in Brazil with an indication in the package insert for the treatment of covid-19, can...
March 12, 2021
Covid-19: Brazilians held up in Portugal return to Brazil on March 10th
Covid-19: Brazilians held up in Portugal return to. Expert living in brazil analysis and reporting from The Rio Times. Latest...
March 4, 2021
No vaccine-related deaths in Brazil, says ANVISA
"The use of data out of context or without the required technical interpretation may lead to false conclusions," alerted the...
March 3, 2021
‘Sputnik V-BR’: Ambassador believes Russian vaccine may be fully produced in Brazil
Russia's ambassador to Brazil, Sergey Akopov, is excited about the prospects of producing the Russian vaccine against SARS-CoV-2, the Sputnik...
February 16, 2021